These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Natural product derived immune-regulatory agents. Talmadge JE Int Immunopharmacol; 2016 Aug; 37():5-15. PubMed ID: 26968760 [TBL] [Abstract][Full Text] [Related]
3. Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders. Mu Y; McManus DP; Hou N; Cai P Front Immunol; 2021; 12():619776. PubMed ID: 33692793 [TBL] [Abstract][Full Text] [Related]
4. [The immunomodulatory and anti-inflammatory properties of different antimicrobial agents]. Guz K; Bugla-Płoskońska G Postepy Hig Med Dosw (Online); 2007 Dec; 61():828-37. PubMed ID: 18097341 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Peptides: An Emerging Category of Therapeutic Agents. Mahlapuu M; Håkansson J; Ringstad L; Björn C Front Cell Infect Microbiol; 2016; 6():194. PubMed ID: 28083516 [TBL] [Abstract][Full Text] [Related]
6. Macrophage Cytological Profiling and Anti-Inflammatory Drug Discovery. Lau TA; Bray WM; Lokey RS Assay Drug Dev Technol; 2019 Jan; 17(1):14-16. PubMed ID: 30657701 [TBL] [Abstract][Full Text] [Related]
8. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Finlay BB; McFadden G Cell; 2006 Feb; 124(4):767-82. PubMed ID: 16497587 [TBL] [Abstract][Full Text] [Related]
9. GSK3β and the control of infectious bacterial diseases. Wang H; Kumar A; Lamont RJ; Scott DA Trends Microbiol; 2014 Apr; 22(4):208-17. PubMed ID: 24618402 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulators as an antimicrobial tool. Pirofski LA; Casadevall A Curr Opin Microbiol; 2006 Oct; 9(5):489-95. PubMed ID: 16931122 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Effector-Mediated Immunity Revealed by the Accidental Human Pathogen Ngwaga T; Chauhan D; Shames SR Front Cell Infect Microbiol; 2020; 10():593823. PubMed ID: 33614523 [TBL] [Abstract][Full Text] [Related]
13. High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries. Pérez Del Palacio J; Díaz C; de la Cruz M; Annang F; Martín J; Pérez-Victoria I; González-Menéndez V; de Pedro N; Tormo JR; Algieri F; Rodriguez-Nogales A; Rodríguez-Cabezas ME; Reyes F; Genilloud O; Vicente F; Gálvez J J Biomol Screen; 2016 Jul; 21(6):567-78. PubMed ID: 26962874 [TBL] [Abstract][Full Text] [Related]
14. Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens. Igietseme JU; Eko FO; He Q; Black CM Expert Rev Vaccines; 2004 Feb; 3(1):23-34. PubMed ID: 14761241 [TBL] [Abstract][Full Text] [Related]
16. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases. Grønbaek Frandsen EV APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832 [TBL] [Abstract][Full Text] [Related]
17. New therapeutic approaches by using microorganism-derived compounds. Amedei A; D'Elios MM Curr Med Chem; 2012; 19(22):3822-40. PubMed ID: 22489726 [TBL] [Abstract][Full Text] [Related]
18. Prediction of molecular mimicry candidates in human pathogenic bacteria. Doxey AC; McConkey BJ Virulence; 2013 Aug; 4(6):453-66. PubMed ID: 23715053 [TBL] [Abstract][Full Text] [Related]